Axsome Therapeutics (AXSM) Tops Q1 EPS by 8c

Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($1.22), $0.08 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $121.46 million versus the consensus estimate of $121.58 million.

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• BNP Paribas Exane Upgrades Novonesis A/S (NSISB:DC) to Neutral
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform